Despite significant medical advancements in the oncology space, 30% of patients in the GSK/Harris Poll survey said they never ...

Gynecologic exams might not top the list of things you look forward to, but whether it's for a wellness visit or a new concern, such exams are critical for detecting gynecologic cancers early when ...

Results from the RAMP 201 clinical trial are promising for patients with recurrent low-grade serous ovarian cancer. This trial is assessing CBX-12 as a potential treatment for ovarian cancer, with ...

Genetic testing is a vital tool in combating hereditary gynecologic cancers, enabling early detection and personalised care.

In each of these gynecologic malignancies, the drugs are routinely employed in combination with a platinum agent, although when delivered as single agents they may provide substantial palliative ...

BioReference team is now able to provide the entire OvaSuite portfolio to healthcare providers in New York and New JerseyAUSTIN, Texas, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Aspira Women’ (“Aspira”) ...

The Fresh Toast - Million of women suffer every month, now science indicates how cannabis can help with dysmenorrhea.

And the incidence of endometrial cancer is growing worldwide, likely due to multiple factors. “One is an aging population, as ...

Mah, MD, of McMaster University in Hamilton, Ontario, Canada, told Medscape Medical News. The researchers’ previous study ...

Dr. Nicole Fleming, a gynecologic oncologist specializing in the treatment of gynecologic malignancies with both surgical and ...

AAGL is the largest medical society focused on gynecologic surgery, with an international membership of over 7,500 physicians and healthcare providers committed to advancing minimally invasive ...

KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless ...